ARCHIVES

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Letter: Legal Fund Seeks Support For Fisher

March 3, 1995

IOM: No Negligence In FIAU Clinical Trial That Killed Five

March 31, 1995

FCRF Recompetition Notice Of Intent

September 19, 1980

AACI Adopts Plan To Step Up Cancer Issues Involvement

January 25, 1980

AIDs Concepts Totaling $13 Million Approved By DCT Board; Will Be Funded By Special Appropriations

October 11, 1985

In Brief: Senate Subcommittee Recommends $1 .52 Billion

September 25, 1987